Top Markets
Coin of the day
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Peringkat dalam Saham #14047
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Harga Saham
$0.88012714
Terakhir disinkronkan: 2026-08-31
Kapitalisasi Pasar
$439.58M
Perubahan (1 hari)
-4.01%
Perubahan (1 tahun)
1,131.97%
Negara
FR
Perdagangan Valerio Therapeutics S.A. (ALVIO)

Kategori

Riwayat harga saham Valerio Therapeutics S.A. (ALVIO)
Harga penutupan tertinggi: $0.91 pada 2026-08-01

Harga penutupan terendah: $0.28 pada 2023-06-01
Riwayat harga saham Valerio Therapeutics S.A. dari 2023 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 53.06%
2025 116.87%
2024 -58.47%
2023 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$544.38 39.22%
US
$1.03K 45.21%
NL
$122.58 -11.06%
AU
$138.80 476.17%
US
$749.90 5.10%
CH